AUA meaningful use recommendations: 6 steps moving forward
Practices should discuss meaningful use with their EHR vendor and determine if they are a certified vendor (CEHRT). Start with focusing on these six specific areas to respond to software changes.
Practices should discuss meaningful use with their EHR vendor and determine if they are a certified vendor (CEHRT). Start with focusing on these six specific areas to respond to software changes:
1. patient health information security: risk analysis/security updates
2. computerized physician order entry and e-prescribing
3. CEHRT for patient data and
for interoperability
4. patient-centric engagement (education, communication, and access)
5. medication
6. public health and clinical data registry guidelines.
The AUA said it is committed to assisting members with meaningful use and other federal quality reporting requirements, and CMS also has a number of resources on its website to help providers better understand the meaningful use program.
“Starting early and with a specific plan, along with tapping CMS resources and partnering with appropriate EHR vendors, will drive successful change and adoption of Stage 3 meaningful use,” according to the AUA.
More from Urology Times:
Meaningful use's directional shift
Meaningful use: Pros and cons of attesting
Smoking associated with greater risk of urolithiasis
Subscribe to Urology Times to get monthly news from the leading news source for urologists.
Prostate cancer genomic tests show prognostic value for progression, therapy benefit
April 22nd 2024"This preplanned ENACT trial biomarker analysis demonstrates the value of the Decipher score, AR-A score, and PAM50 genomic classifiers in identifying patients undergoing AS who are most likely to benefit from enzalutamide treatment," wrote the authors.
Updated data show survival benefit with adjuvant pembrolizumab in ccRCC
April 19th 2024“This is the first study to show a statistically significant and clinically meaningful survival improvement with any adjuvant therapy in kidney cancer, and this further supports adjuvant pembrolizumab as a standard of care after surgery in this disease setting,” says Toni K. Choueiri, MD.
